1-8 of 8
taliglucerase alfa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bone Marrow Involvement in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long Term Enzyme Replacement Therapy (median 18 years)

Shoshana Revel-Vilk, MD, Jeffrey Szer, MBBS, Michal Becker Cohen, Ari Zimran, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4862.
https://doi.org/10.1182/blood-2019-131013
Published: 2019
Journal Articles

Open-Label, Expanded Access Study of Taliglucerase Alfa in Patients with Gaucher Disease Requiring Enzyme Replacement Therapy

David J. Kuter, MD DPhil, Michael Wajnrajch, MD MPA, Betina Hernandez, MD, Rong Wang, MPH, Raul Chertkoff, MD MBA, Ari Zimran, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3755.
https://doi.org/10.1182/blood-2018-99-112660
Published: 2018
Journal Articles

Novel Management of Immune Thrombocytopenia in Gaucher Disease Patients

Hanna Rosenbaum, MD
Journal: Blood
Blood (2014) 124 (21): 5006.
https://doi.org/10.1182/blood.V124.21.5006.5006
Published: 2014
Journal Articles

Persistence of Imiglucerase in Cell Compartment Explains Dosing Frequency of Every Two Weeks in Type 1 Gaucher Disease

Juliette Berger, PhD, Marie Vigan, PhD, Jérôme Stirnemann, PD, PhD Professor, Céline Bourgne, PhD, Alexandre Janel, PhD, Nadia Belmatoug, MD, Christian Rose, MD, Monia Bengherbia, Bruno Pereira, France Mentré, MD PhD Professor, Marc G Berger, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1396.
https://doi.org/10.1182/blood.V124.21.1396.1396
Published: 2014
Journal Articles

A Multicenter, Double-Blind, Randomized Safety and Efficacy Study of Two Dose Levels of Taliglucerase Alfa in Pediatric Patients with Gaucher Disease.

Ari Zimran, MD, Derlis Emilio Gonzalez-Rodriguez, MD, Aya Abrahamov, MD, Deborah Elstein, PhD, Rene Heitner, MD, Alona Paz, MD, Einat Brill-Almon, PhD, Raul Chertkoff, MD
Journal: Blood
Blood (2012) 120 (21): 2140.
https://doi.org/10.1182/blood.V120.21.2140.2140
Published: 2012
Journal Articles

Zimran A, Brill-Almon E, Chertkoff R, et al. Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood . 2011;118(22): 5767–5773 .

Ari Zimran, Einat Brill-Almon, Raul Chertkoff, Milan Petakov, Francisco Blanco-Favela, Eduardo Terreros Muñoz, Sergio E. Solorio-Meza, Dominick Amato, Gloria Duran, Fiorina Giona, Rene Heitner, Hanna Rosenbaum, Pilar Giraldo, Atul Mehta, Glen Park, Mici Phillips, Deborah Elstein, Gheona Altarescu, Mali Szleifer, Sharon Hashmueli, David Aviezer
Journal: Blood
Blood (2012) 119 (19): 4577.
https://doi.org/10.1182/blood-2012-01-408054
Published: 2012
Journal Articles

Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease

Clinical Trials & Observations
Ari Zimran, Einat Brill-Almon, Raul Chertkoff, Milan Petakov, Francisco Blanco-Favela, Eduardo Terreros Muñoz, Sergio E. Solorio-Meza, Dominick Amato, Gloria Duran, Fiorina Giona, Rene Heitner, Hanna Rosenbaum, Pilar Giraldo, Atul Mehta, Glen Park, Mici Phillips, Deborah Elstein, Gheona Altarescu, Mali Szleifer, Sharon Hashmueli, David Aviezer
Journal: Blood
Blood (2011) 118 (22): 5767–5773.
https://doi.org/10.1182/blood-2011-07-366955
Published: 2011
Journal Articles

The Uptake of Recombinant Glucocerebrosidases by Blood Monocytes From Type 1 Gaucher Disease Patients Is Heterogeneous

Juliette Berger, Jérome Stirnemann, MD, PhD, Céline Bourgne, Bruno Pereira, Pascale Pigeon, Djazia Heraoui, Chantal Rapatel, Christian Rose, MD, PhD, Nadia Belmatoug, MD, Marc G Berger, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1102.
https://doi.org/10.1182/blood.V118.21.1102.1102
Published: 2011